Transdiagnostic Associations between Anger Hostility and Chemokine Interferon-gamma Inducible Protein 10
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Many psychiatric disorders are linked to low grade systemic inflammation as measured by systemic cytokine levels. Exploration of cytokines and immune activity and their role in psychiatric symptoms may inform pathobiology and treatment opportunities. The aim of this study is to explore if there are associations between cytokines and psychiatric symptom clusters. Comparison between patients regularly using and those not using psychotropic medication is also conducted. Methods: This was a cross sectional naturalistic study with 132 participants from a general open inpatient psychiatric ward at the Nordland Hospital Trust, Norway. Serum levels of 28 different cytokines were assessed. Psychiatric symptoms the last week were assessed by a self-rating scale (Symptom check list, SCL-90-R) and grouped in defined clusters. Multiple linear regression model was used for statistical analyses of associations between levels of cytokines and symptoms, adjusting for possible confounding factors. Results: We found a positive association (p = 0.009) between the chemokine interferon-gamma inducible protein 10 (CXCL 10; IP-10) and the anger hostility cluster. No associations were found between the other symptom clusters and cytokines. IP-10 and the anger hostility cluster were positively associated (p = 0.002) in the subgroup of patients using psychotropic medication, not in the subgroup not using psychotropic medication. Conclusion: Our analyses revealed a significant positive association between the symptom cluster anger hostility in SCL-90-R and the chemokine IP-10 in the subgroup of patients using psychotropic medications.
Abstract
Objective: Many psychiatric disorders are linked to low grade systemic inflammation as measured by systemic cytokine levels. Exploration of cytokines and immune activity and their role in psychiatric symptoms may inform pathobiology and treatment opportunities. The aim of this study is to explore if there are associations between cytokines and psychiatric symptom clusters. Comparison between patients regularly using and those not using psychotropic medication is also conducted. Methods: This was a cross sectional naturalistic study with 132 participants from a general open inpatient psychiatric ward at the Nordland Hospital Trust, Norway. Serum levels of 28 different cytokines were assessed. Psychiatric symptoms the last week were assessed by a self-rating scale (Symptom check list, SCL-90-R) and grouped in defined clusters. Multiple linear regression model was used for statistical analyses of associations between levels of cytokines and symptoms, adjusting for possible confounding factors. Results: We found a positive association (p = 0.009) between the chemokine interferon-gamma inducible protein 10 (CXCL 10; IP-10) and the anger hostility cluster. No associations were found between the other symptom clusters and cytokines. IP-10 and the anger hostility cluster were positively associated (p = 0.002) in the subgroup of patients using psychotropic medication, not in the subgroup not using psychotropic medication. Conclusion: Our analyses revealed a significant positive association between the symptom cluster anger hostility in SCL-90-R and the chemokine IP-10 in the subgroup of patients using psychotropic medications.
참고문헌 (54)
- Miller AH, "Cytokine targets in the brain : impact on neurotransmitters and neurocircuits", Depress Anxiety, 30, pp.297~306 (2013)
- Haroon E, "Psychoneuroimmunology meets neuropsychopharmacology : translational implications of the impact of inflammation on behavior", Neuropsychopharmacology, 37, pp.137~162 (2012)
- Salvador AF, "Neuromodulation by the immune system : a focus on cytokines", Nat Rev Immunol, 21, pp.526~541 (2021)
- Conti CM, "Interlationship between psychology and cytokines", J Biol Regul Homeost Agents, 24, pp.485~490 (2010)
- Yuan N, "Inflammation-related biomarkers in major psychiatric disorders : a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses", Transl Psychiatry, 9, pp.233~ (2019)
- Dantzer R, "From inflammation to sickness and depression : when the immune system subjugates the brain", Nat Rev Neurosci, 9, pp.46~56 (2008)
- Takahashi A, "Aggression, social stress, and the immune system in humans and animal models", Front Behav Neurosci, 12, pp.56~ (2018)
- Hyman SE, "Grouping diagnoses of mental disorders by their common risk factors", Am J Psychiatry, 168, pp.1~3 (2011)
- van Beveren NJ, "Clinical utility of serum biomarkers for major psychiatric disorders", Int Rev Neurobiol, 101, pp.351~374 (2011)
- Bebbington P, "Categories, continua and the growth of psychiatric knowledge", Soc Psychiatry Psychiatr Epidemiol, 50, pp.507~510 (2015)
- Anderson G, "Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome", Acta Psychiatr Scand, 129, pp.83~97 (2014)
- Lakhan SE, "Biomarkers in psychiatry : drawbacks and potential for misuse", Int Arch Med, 3, pp.1~ (2010)
- Freed RD, "Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions", World J Biol Psychiatry, 20, pp.712~722 (2019)
- Groven N, "Patients with Fibromyalgia and Chronic Fatigue Syndrome show increased hsCRP compared to healthy controls", Brain Behav Immun, 81, pp.172~177 (2019)
- Soloey-Nilsen H, "Association between brainderived neurotropic factor(BDNF), high-sensitivity C-reactive protein(hs-CRP)and psychiatric symptoms in medicated and unmedicated patients", BMC Psychiatry, 22, pp.84~ (2022)
- Larsen JB, "Cytokines in agitated and non-agitated patients admitted to an acute psychiatric department : a cross-sectional study", PLoS One, 14, pp.e0222242~ (2019)
- Özaslan A, "Increased serum level of CCL5 in children with attention‑deficit", hyperactivity disorder : first results about serum chemokines, 2022, pp.20, 109~117
- Milaneschi Y, "Depression heterogeneity and its biological underpinnings : toward immunometabolic depression", Biol Psychiatry, 88, pp.369~380 (2020)
- Reddy PV, "Multiple complement pathway-related proteins might regulate immunopathogenesis of major depressive disorder", Clin Psychopharmacol Neurosci, 21, pp.313~319 (2023)
- Schmitz N, "The Symptom Check-List-90-R(SCL-90-R) : a German validation study", Qual Life Res, 9, pp.185~193 (2000)
- Leavitt C, "Interferon gamma-induced protein 10(IP-10)and cardiovascular disease in African Americans", PLoS One, 15, pp.e0231013~ (2020)
- Liu M, "CXCL10", IP-10 in infectious diseases pathogenesis and potential therapeutic implications, 2011, pp.22, 121~130
- Stuart MJ, "Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment : a systematic review of biomarker studies", Neurosci Biobehav Rev, 42, pp.93~115 (2014)
- Wong ML, "Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response", Mol Psychiatry, 13, pp.800~812 (2008)
- Blank T, "Brain endothelial-and epithelialspecific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment", Immunity, 44, pp.901~912 (2016)
- Kiecolt-Glaser JK, "Inflammation : depression fans the flames and feasts on the heat", Am J Psychiatry, 172, pp.1075~1091 (2015)
- Camacho-Arroyo I, "Chemokine profile in women with moderate to severe anxiety and depression during pregnancy", BMC Pregnancy Childbirth, 21, pp.807~ (2021)
- Clark C, "Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people", J Neuroinflammation, 19, pp.127~ (2022)
- Gaarden TL, "Exploration of 27 plasma immune markers : a cross-sectional comparison of 64 old psychiatric inpatients having unipolar major depression and 18 non-depressed old persons", BMC Geriatr, 18, pp.149~ (2018)
- Benedetti F, "Higher baseline proinflammatory cytokines mark poor antidepressant response in bipolar disorder", J Clin Psychiatry, 78, pp.e986~e993 (2017)
- Poletti S, "Markers of neuroinflammation influence measures of cortical thickness in bipolar depression", Psychiatry Res Neuroimaging, 285, pp.64~66 (2019)
- Simon NM, "A detailed examination of cytokine abnormalities in Major Depressive Disorder", Eur Neuropsychopharmacol, 18, pp.230~233 (2008)
- Hoge EA, "Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder", Depress Anxiety, 26, pp.447~455 (2009)
- Goldsmith DR, "A meta-analysis of blood cytokine network alterations in psychiatric patients : comparisons between schizophrenia, bipolar disorder and depression", Mol Psychiatry, 21, pp.1696~1709 (2016)
- Carvalho AF, "Bias in emerging biomarkers for bipolar disorder", Psychol Med, 46, pp.2287~2297 (2016)
- Skibinska M, "Brain-derived neurotrophic factor(BDNF)serum level in women with first-episode depression, correlation with clinical and metabolic parameters", Nord J Psychiatry, 72, pp.191~196 (2018)
- Hennø LT, "Effect of the anticoagulant, storage time and temperature of blood samples on the concentrations of 27multiplex assayed cytokines-consequences for defining reference values in healthy humans", Cytokine, 97, pp.86~95 (2017)
- Schmidt FM, "Inflammation and immune regulation as potential drug targets in antidepressant treatment", Curr Neuropharmacol, 14, pp.674~687 (2016)
- Munzer A, "Impact of antidepressants on cytokine production of depressed patients in vitro", Toxins(Basel), 5, pp.2227~2240 (2013)
- Strawbridge R, "Inflammation and clinical response to treatment in depression : a meta-analysis", Eur Neuropsychopharmacol, 25, pp.1532~1543 (2015)
- Tsai JH, "Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes", Int J Mol Sci, 15, pp.13223~13235 (2014)
- de la Peña FR, "Serum levels of chemokines in adolescents with major depression treated with fluoxetine", World J Psychiatry, 10, pp.175~186 (2020)
- Syed SA, "Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response", Neuron, 99, pp.914~924 (2018)
- Cavalcanti J, "Psychometric parameters of the subscale of hostility from the Symptom Checklist 90(SCL-90)", Psico-USF, 24, pp.373~381 (2019)
- Smits IAM, "The Dutch Symptom Checklist-90-Revised : is the use of the subscales justified?", Eur J Psychol Assess, 31, pp.263~271 (2015)
- Siegel A, "The neurobiological bases for development of pharmacological treatments of aggressive disorders", Curr Neuropharmacol, 5, pp.135~147 (2007)
- Kraus MR, "Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy", J Clin Psychiatry, 64, pp.708~714 (2003)
- Pesce M, "Biological role of interleukin-1beta in defensive-aggressive behaviour", J Biol Regul Homeost Agents, 25, pp.323~329 (2011)
- Pesce M, "Biological role of interleukin-1beta in defensive-aggressive behaviour", J Biol Regul Homeost Agents, 25, pp.323~329 (2011)
- Koh KB, "Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders", J Clin Psychiatry, 63, pp.486~492 (2002)
- Boyle SH, "Hostility, anger, and depression predict increases in C3 over a 10-year period", Brain Behav Immun, 21, pp.816~823 (2007)
- Larsen JB, "Cytokines in relation to motor activity in an acute psychiatric population", Front Psychiatry, 10, pp.920~ (2019)
- Harlow LL, "Book review of using multivariate statistics by Barbara G. Tabachnick and Linda S. Fidell", Struct Equ Modeling, 9, pp.621~636 (2002)
- Haack M, "Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures", Psychoneuroendocrinology, 27, pp.921~931 (2002)
